Ignite Creation Date:
2025-12-24 @ 7:11 PM
Ignite Modification Date:
2026-03-03 @ 4:08 PM
Study NCT ID:
NCT02122003
Status:
TERMINATED
Last Update Posted:
2017-11-22
First Post:
2014-04-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Second Line Sorafenib After Pazopanib in Patients With RCC
Sponsor:
Organization: